Audit Plan- Glaxosmithkline - 4420 Words

Audit Plan- GlaxoSmithKline (GSK) Key business and audit risk: In order to make the report more efficient we must identify the key areas of business risk and auditing risk. Business risk can be defined as the risk, which could affect an organization’s ability to achieve its objectives (Gray and Manson, 2007). Audit risk is defined as the risk that the auditor gives an inappropriate audit opinion when the financial statements are materially misstated (Soltani, 2007). In Gray and Manson (2007)’s book Audit Risk can be split into three separate elements : 1- Inherent risk reflects the auditor’s opinion on the possibility of material misstatement on financial statement. 2- Control risk is the risk that internal control policies and†¦show more content†¦Firstly, misstatement via the means of non-existent sales or sales which have been realised in the incorrect period. Secondly sales may not be recorded in order to lower sales so provide evidence in further periods of higher growth than is actually correct. Thirdly sales could be incorrectly entered into the system providing incorrect figures. Therefore one would need to verify the sales books, and the controls in place to prevent errors either intentional or unintentional. Debts The level of debt that a company holds and their ability to repay this debt is an important risk factor for GSK. There is a higher risk for GSK than for some of its competitors, as GSK has a higher leverage than the likes of Pfizer and JJ (Financial Times, 2010). However this in itself can in some cases be more efficient as long as the entity has the cash flow in order to repay these debts. Therefore one has to ensure during the audit that GSK will have sufficient cash flows to meet its repayments for the year. Cash management Sufficient liquid cash in a company is important to defend against economic uncertainty. A small cash reserve/ cash flow, can be a control and detection risk, which may result profitable projects having to be scrapped or assets sold to increase cash flow Also one has to ensure that the book values for GSK’s debtor and creditors are correct and verified as they make up large sections of the balance sheet and a misstatement of these values wouldShow MoreRelatedGlaxoSmithKline In China CaseAnalysis Essay1718 Words   |  7 Pagesmainly imports and exports. In 1904, Joseph attained the rights to produce dried up milk which was later sold as baby food called Glaxo. GlaxoSmithKline got its name in the early 1990’s after Glaxo a pharmaceutical firm created in New Zeeland merged with SmithKline, which was also a Pharmaceutical, firm in the United Kingdom. Several years after the merger, GlaxoSmithKline (GSK) became one of the largest drug manufacturers around, with an estimate of $22.5 billion in global sales and had over one hundredRead More An Analysis of GlaxoSmithKline Essay11294 Words   |  46 PagesAn Analysis of GlaxoSmithKline The business that I have done research into is GlaxoSmithKline. This company is a globalised research-based pharmaceutical public limited company. Its ownership structure has changed a great deal since the original company was first established in 1715. Originally a pharmacy, the company has expanded, merged with and taken over other companies over the decades. The last of these was the merger between Glaxo Wellcome and SmithKline Beecham, which formed theRead MoreGsk Annual Report 2010135604 Words   |  543 PagesDo more, feel better, live longer GlaxoSmithKline Annual Report 2010 Contents Business review P08–P57 Governance and remuneration P58–P101 Financial statements P102–P191 Shareholder information P192–P212 Business review 2010 Performance overview Research and development Pipeline summary Products, competition and intellectual property Regulation Manufacturing and supply World market GSK sales performance Segment reviews Responsible business Financial review 2010 Financial position and resourcesRead MoreExample of Change Management3813 Words   |  16 PagesGlaxoSmithKline CHANGE MANAGEMENT GlaxoSmithKline The change situation that has been chosen is the cultural change and post merger integration of the Ramp;D department of the company in 2000. During the process, an organization is experiencing a change, how the organization finds, decides and forms its figures are the most important aspects for its future. The ability to change means a tacit process, prepositional concept that lies in the bottom line, because explicit skills are after allRead MoreMergers Acquisitions in Pharma Industry21425 Words   |  86 PagesPROJECT REPORT ON A Successful International Merger in India: GlaxoSmithKline pharmaceutical industry Table of Contents: Declaration Abstract Part I –Introduction Research Objective and justifications Report Outline Part-II Industry DescriptionRead MoreGlaxosmithkline18561 Words   |  75 PagesGlaxoSmithKline company profile Francis Weyzig Amsterdam, October 2004 Summary Business description GlaxoSmithKline (GSK) is one of the world’s largest research-based pharmaceutical corporations that discovers, develops, manufactures and markets branded human health products. Headquarters: UK, with additional operational headquarters in the USA Global presence: about 160 countries Primary markets: USA, France, Germany, UK, Italy and Japan Employees: approximately 103,000 GSK key figuresRead MoreSupply Chain Sustainability at Gsk4373 Words   |  18 Pageschain process? ; How they achieve sustainability in the supply chain process? ; What are the major steps taken by GSK to collaborate with its suppliers in terms of economic and social sustainability? GLAXOSMITHKLINE - A SUSTAINABLE SUPPLY CHAIN A. Company Overview Mission: GlaxoSmithKline one of the worlds leading research-based pharmaceutical and healthcare companies is committed to improving the quality of human life by enabling people to do more, feel better and live longer†.(Website) Read MoreStandard Costing Procedure and Cost Variance Analysis of Glaxosmithkline Bangladesh Ltd13705 Words   |  55 PagesInternship Report On Standard Costing Procedure Cost Variance Analysis: A Study on GlaxoSmithKline Bd. Ltd. Submitted To Mr. Syed Manzur Quader Lecturer Independent University, Bangladesh Chittagong Submitted By TASBEER AKTAR ABEER ID#0311022 Independent University, Bangladesh Date of Submission: 10th September, 2007 Letter of Transmittal Monday, September 10, 2007 To Mr. Syed Manzur Quader Lecturer, Independent University, Bangladesh Chittagong Sub: Submission of Internship Report.Read MoreMarketing Plan for New Pepsi Product Essay1953 Words   |  8 PagesMarketing Plan: Phase Two The A-Team has introduced a new product called Pepsi Platinum for the company, PepsiCo, in Phase Two. This dissertation will identify segmentation criteria that will impact PepsiCo target market selection. This dissertation will describe the organizational buyers and consumers of Pepsi Platinum and factors that influence their purchasing decisions and discuss how these factors will impact PepsiCo’s marketing strategy. Finally, this phase shall analyze current competitorsRead MoreThe Innovation Challenge Through Transformational Leadership, Followership And Hrm Techniques Essay1926 Words   |  8 Pagesemployees is 61500 (AstraZeneca, 2015). Their main competitors are GlaxoSmithKline Amgen. The purpose of AstraZeneca is to promote scientific advancements through innovative science and sustainable development to provide life-changing medicines to patients. So, they have a clear vision: to be a global company which focused in core therapy areas (AstraZeneca, 2016). Besides, com pany’s main organizational structure including: Board, audit committee, remuneration committee, nomination and governance committee